Synthesis, <i>in Vitro</i> and <i>in Silico</i> Studies of Some Novel 5-Nitrofuran-2-yl Hydrazones as Antimicrobial and Antitubercular Agents
作者:Hatem Abdel-Kader Abdel-Aziz、Wagdy Mohamed Eldehna、Mohamed Fares、Tilal Elsaman、Marwa Mostafa Abdel-Aziz、Dalia Hussein Soliman
DOI:10.1248/bpb.b15-00439
日期:——
In this study, we synthesized two series of novel 5-nitrofuran-2-carbohydrazides 21a–h and 22a–e in addition to a third series of thiophene-2-carbohydrazides 23a–g to develop potent antimicrobial and/or antitubercular agents. The newly synthesized compounds were evaluated in vitro for their antimicrobial and antimycobacterial activities. Most of the 5-nitrofuran-2-carbohydrazides 21a–h and 22a–e displayed variable activity against Aspergillus fumigates, Staphylococcus aureus, Streptococcus pneumonia, Bacillis subtilis, Salmonella typhimurium, Klebsiella pneumonia, Escherichia coli and Mycobacterium tuberculosis. The sulfonamide derivative 21f exhibited superior potency and broad-spectrum antimicrobial activity with minimum inhibitory concentration (MIC)=0.06–0.98 µg/mL and antimycobacterial activity with MIC=3.9 µg/mL. The 5-nitrofuran-2-carbohydrazides 21a, b, g, h and 22a–c exhibited significant antibacterial activity with MIC values in the range of 0.12–7.81 µg/mL. The significances of the 5-nitrofuran moiety and sulfonamide function were explored via the structure–activity relationship (SAR) study. In addition, docking studies revealed that the p-amino benzoic acid (PABA) and binding pockets of the dihydropteroate synthase (DHPS) were successfully occupied by compound 21f. Furthermore, two quantitative structure–activity relationship (QSAR) models were built to explore the structural requirements which controlled the activity.
在本研究中,我们合成了两系列新型5-硝基呋喃-2-甲酰肼21a–h和22a–e,以及第三系列噻吩-2-甲酰肼23a–g,旨在开发强效抗菌和/或抗结核剂。新合成的化合物在体外进行了抗菌和抗分枝杆菌活性评估。大多数5-硝基呋喃-2-甲酰肼21a–h和22a–e对烟曲霉、金黄色葡萄球菌、肺炎链球菌、枯草芽孢杆菌、鼠伤寒沙门氏菌、肺炎克雷伯菌、大肠埃希菌和结核分枝杆菌显示出不同程度的活性。磺胺衍生物21f表现出优越的广谱抗菌活性,最小抑制浓度(MIC)=0.06–0.98 µg/mL,以及抗分枝杆菌活性,MIC=3.9 µg/mL。5-硝基呋喃-2-甲酰肼21a、b、g、h和22a–c显示出显著的抗菌活性,MIC值在0.12–7.81 µg/mL范围内。通过结构-活性关系(SAR)研究探讨了5-硝基呋喃部分和磺胺功能的重要性。此外,对接研究揭示了化合物21f成功占据了对氨基苯甲酸(PABA)和二氢蝶酸合酶(DHPS)的结合口袋。进一步地,构建了两个定量结构-活性关系(QSAR)模型,以探索控制活性的结构要求。